{"id":6344,"date":"2026-03-07T23:03:15","date_gmt":"2026-03-08T04:03:15","guid":{"rendered":"https:\/\/mivado.com\/eshop\/?post_type=etn&#038;p=6344"},"modified":"2026-05-23T20:59:33","modified_gmt":"2026-05-24T00:59:33","slug":"advanced-biopharma-stability-program-design","status":"publish","type":"etn","link":"https:\/\/mivado.com\/eshop\/m_event\/advanced-biopharma-stability-program-design\/","title":{"rendered":"Advanced Biopharma Stability Program Design"},"content":{"rendered":"<h2>Advanced Biopharma Stability Program Design<\/h2>\n<p>Two-Day Training<\/p>\n<h2><span style=\"font-weight: 400;\">Overview<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">This two-day advanced training is designed for professionals in the biopharmaceutical, pharmaceutical, and medical device industries who are involved in stability program development. The program will cover key regulatory requirements, best practices for study design, data analysis, and risk management. Participants will gain the skills to design robust stability programs that comply with global guidelines (ICH, FDA, EMA) while optimizing product shelf life and quality.\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">This training aligns with industry needs by ensuring compliance, reducing regulatory risks, and improving product stability strategies.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Learning Objectives<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">By the end of this training, participants will be able to:\u00a0\u00a0<\/span><\/p>\n<ul>\n<li><span style=\"font-weight: 400;\">Apply ICH guidelines (Q1A, Q5C) to design stability studies for biopharmaceuticals.\u00a0\u00a0<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Develop a stability study protocol with appropriate storage conditions, sampling points, and test methods.\u00a0\u00a0<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Analyze stability data using statistical tools to predict shelf life and degradation trends.\u00a0\u00a0<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Mitigate risks in stability programs by identifying critical variables and failure modes.\u00a0\u00a0<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Implement strategies for handling deviations and out-of-specification (OOS) results.\u00a0\u00a0<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Present stability data effectively for regulatory submissions.\u00a0\u00a0<\/span><\/li>\n<\/ul>\n<h2><span style=\"font-weight: 400;\">Key Topics\u00a0<\/span><\/h2>\n<p><span style=\"font-weight: 400;\"><strong>Module 1<\/strong>: Introduction to Stability Studies in Biopharma <\/span><span style=\"font-weight: 400;\">&#8211; Importance, objectives, and industry challenges.\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\"><strong>Module 2<\/strong>: Regulatory Guidelines (ICH, FDA, EMA)<\/span><span style=\"font-weight: 400;\">\u00a0&#8211; Key requirements for stability testing in biologics.\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\"><strong>Module 3<\/strong>: Stability Study Design &amp; Protocol Development<\/span><span style=\"font-weight: 400;\">\u00a0&#8211; Selection of batches, storage conditions, and test intervals.\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\"><strong>Module 4<\/strong>: Case Study: Stability Protocol Review<\/span><span style=\"font-weight: 400;\">\u00a0&#8211; Hands-on evaluation of a real-world protocol.\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\"><strong>Module 5<\/strong>: Stability Data Evaluation &amp; Statistical Tools<\/span><span style=\"font-weight: 400;\">\u00a0&#8211; Trend analysis, shelf-life estimation (ANOVA, regression).\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\"><strong>Module 6<\/strong>: Handling OOS &amp; Deviations in Stability Studies <\/span><span style=\"font-weight: 400;\">&#8211; Root cause analysis and corrective actions.\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\"><strong>Module 7<\/strong>: Risk-Based Stability Program Optimization<\/span><span style=\"font-weight: 400;\">\u00a0&#8211; Identifying critical parameters and failure modes.\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\"><strong>Module 8<\/strong>: Regulatory Submissions &amp; Mock Audit Exercise<\/span><span style=\"font-weight: 400;\">\u00a0&#8211; Preparing stability reports for inspections.\u00a0\u00a0<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Assessment &amp; Interaction\u00a0<\/span><\/h2>\n<ul>\n<li><span style=\"font-weight: 400;\">Quizzes after key modules.\u00a0 <\/span><\/li>\n<li>Group exercises (protocol drafting, data analysis).<\/li>\n<li>Feedback forms for continuous improvement.<\/li>\n<\/ul>\n<h2><span style=\"font-weight: 400;\">Target Audience<\/span><\/h2>\n<ul>\n<li><span style=\"font-weight: 400;\">Roles: Stability scientists, QA\/QC professionals, regulatory affairs specialists, formulation scientists.\u00a0 <\/span><\/li>\n<li>Prerequisites: Basic knowledge of GMP, stability testing principles, and biopharmaceutical product development.<\/li>\n<\/ul>\n<h2><span style=\"font-weight: 400;\">Key Takeaways\u00a0<\/span><\/h2>\n<ul>\n<li><span style=\"font-weight: 400;\">Master stability study design aligned with ICH guidelines.\u00a0\u00a0<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Apply statistical methods for shelf-life prediction.\u00a0\u00a0<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Develop risk-based stability strategies for compliance.\u00a0\u00a0<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Enhance regulatory submission readiness.\u00a0\u00a0<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Resolve stability-related deviations effectively.\u00a0 <\/span><\/li>\n<\/ul>\n<h2>Speaker<\/h2>\n<p><a href=\"https:\/\/ca.linkedin.com\/in\/kossi-molley-3534923\" target=\"_blank\" rel=\"noopener\">Kossi Molley, Chimiste, LSSBB, PMP<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Advanced Biopharma Stability Program Design Two-Day Training Overview This two-day advanced training is designed for professionals in the biopharmaceutical, pharmaceutical, and medical device industries who are involved in stability program development. The program will cover key regulatory requirements, best practices for study design, data analysis, and risk management. Participants will gain the skills to design<\/p>\n<div class=\"clearfix\"><\/div>\n<div class=\"pull-left padding-top-25\"><a href=\"https:\/\/mivado.com\/eshop\/m_event\/advanced-biopharma-stability-program-design\/\" class=\"btn btn-theme\">Continue Reading <span class=\"screen-reader-text\"> &#8220;Advanced Biopharma Stability Program Design&#8221;<\/span> <i class=\"fa fa-fw fa-long-arrow-right\"><\/i> <\/a>  <\/div>\n","protected":false},"author":2,"featured_media":6319,"parent":0,"template":"","etn_category":[25,199],"etn_tags":[200,30,31,37,202,205],"class_list":["post-6344","etn","type-etn","status-publish","has-post-thumbnail","hentry","etn_category-english","etn_category-masterclass","etn_tags-capa","etn_tags-gdp","etn_tags-gmp","etn_tags-quality","etn_tags-quality-control","etn_tags-stability"],"tutor_lms_mapping":{},"_links":{"self":[{"href":"https:\/\/mivado.com\/eshop\/wp-json\/wp\/v2\/etn\/6344","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mivado.com\/eshop\/wp-json\/wp\/v2\/etn"}],"about":[{"href":"https:\/\/mivado.com\/eshop\/wp-json\/wp\/v2\/types\/etn"}],"author":[{"embeddable":true,"href":"https:\/\/mivado.com\/eshop\/wp-json\/wp\/v2\/users\/2"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mivado.com\/eshop\/wp-json\/wp\/v2\/media\/6319"}],"wp:attachment":[{"href":"https:\/\/mivado.com\/eshop\/wp-json\/wp\/v2\/media?parent=6344"}],"wp:term":[{"taxonomy":"etn_category","embeddable":true,"href":"https:\/\/mivado.com\/eshop\/wp-json\/wp\/v2\/etn_category?post=6344"},{"taxonomy":"etn_tags","embeddable":true,"href":"https:\/\/mivado.com\/eshop\/wp-json\/wp\/v2\/etn_tags?post=6344"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}